logo
Plus   Neg
Share
Email

Rhoen-Klinikum Q3 EBITDA Down; Confirms 2017 Outlook

German hospital operator Rhoen-Klinikum AG (RKKPF.PK) reported that its third-quarter earnings before interest, taxes, depreciation and amortisation or EBITDA declined to 27.4 million euros from 28.1 million euros last year.

But, revenues rose by 3.2 percent to 304.0 million euros from the previous year's 294.7 million euros.

Rhoen-Klinikum said that it treated 3.7 percent more patients in the third quarter of the current financial year than in the same quarter of last year.

The company confirmed its forecast for the current financial year of 2017 and expects revenues of between 1.20 billion euros and 1.23 billion euros and earnings before interest, taxes, depreciation and amortisation (EBITDA) of between 85 million euros and 105 million euros. This includes negative effects in a low two-digit million figure due to additional expense from digitalising medical processes and one-off burdens from group restructuring. The company expects EBITDA to be within the upper half of the range when full legal ratification takes place.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Down the line, GE has transformed from a too-big-to-fail conglomerate to a too-big-for-success albatross. The company has admitted to being too-much focused on EPS and operating profit, and not paying enough attention to cash. However, GE is certainly learning lessons from its past and refocusing its strategies to stage a comeback to its Camelot days, the key catalysts being... Industrial conglomerate General Electric Co., one of the original components of the Dow Jones Industrial Average, has been replaced by Walgreens Boots Alliance Inc. in the blue-chip index. The change comes into effect prior to the open of trading on Tuesday, June 26. The 122-year-old Dow Jones Industrial Average, or simply the Dow, is a stock market index with 30 component companies. A $716 billion defense policy bill easily cleared the Senate on Monday, although the legislation must still be reconciled with the version previously approved by the House. The Senate voted 85 to 10 in favor of the National Defense Authorization Act, which authorizes U.S. military spending for fiscal 2019.
Follow RTT